The role of the different actors in controlling the costs of the medicine use in Belgium.

In the area of production, distribution, payment, prescription and the use of medicines, several protagonists can be identified. Insight into the importance of and in the underlying relationships between these actors, and of the relative impact of these actors on the system as a whole, is necessary. In the European context, little research has been done on this subject. Knowledge on this subject is necessary for the survival of the health care system in Belgium.

Keywords:HEALTH CARE ORGANISATION, MEDICINE CONSUMPTION, HEALTH ECONOMICS, HEALTH CARE COST

Disciplines:Public health care, Public health sciences, Public health services, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences